Description

Technical Parameters

Semaglutide 2mg/bottle Core Introduction

Pharmaceutical -grade lyophilized powder | Long-acting GLP-1 receptor agonist

Chemical structure : GLP-1 analogue with fatty acid side chain

Molecular weight : approximately 4,113 Da

Purity : ≥98% (HPLC)

Specifications : 2 mg/vial (approximately 1.34 mg/mL)

Appearance : White freeze-dried powder

Solvent : 1.5mL bacteriostatic water

Core Effects

Semaglutide is an ultra-long-acting GLP-1 receptor agonist . Due to its excellent glucose-lowering and weight-loss effects, as well as cardiovascular protective effects , it is widely used in the treatment of type 2 diabetes, obesity management, and cardiovascular risk control .

✅ Powerful blood sugar control :

Glucose- dependent hypoglycemic effect : stimulates insulin secretion only when blood sugar is elevated

Lowers A1C : 1.5-2.0%

✅ Significant weight loss :

Central appetite suppression : Acts on the hypothalamic satiety center

Clinical studies show an average weight loss of 15-18% over 68 weeks

✅ Reduced risk of cardiovascular events :

of major adverse cardiovascular events (MACE)

Improving cardiovascular risk factors : The combined benefits of lowering blood pressure and regulating lipids

✅ Advantages of use :

Ultra-long half-life : approximately 7 days, once-weekly dosing

Multiple metabolic benefits : blood sugar reduction, weight loss, and cardiovascular protection

Usage Protocol

1. Recombination method :

Draw 1.5mL of solvent into the syringe and slowly inject it along the wall of the bottle

Gently rotate to dissolve , do not shake violently

Storage after reconstitution : Refrigerate at 2-8°C and use within 56 days

2. Injection protocol :

Injection route : Subcutaneous injection (abdomen, thigh, upper arm)

Starting dose : 0.25 mg/week for 4 weeks

the dose by 0.25 mg every month until the maintenance dose is reached

Maintenance dose : 0.5-1.0 mg/week, maximum dose 2.4 mg/week

3. Treatment options :

Type 2 diabetes :

Initially 0.25 mg/week, then maintain 0.5–1.0 mg/week

Adjust dosage based on blood glucose monitoring results

Obesity Management :

Initially 0.25 mg/week, gradually increasing to 2.4 mg/week

Combining diet and exercise

Storage Guidelines

1. Unrestored :

Temperature : 2-8°C refrigerated, do not freeze

Humidity : Relative humidity ≤ 60%

Expiration date : 30 months (2-8°C)

2. Storage after reconstitution :

Store in refrigerator : 2-8°C for up to 56 days

Avoid freezing : Freeze-thawing can damage protein structure

Light protection : Store in original packaging away from light

Why choose semaglutide ?

Ultra-long-acting GLP-1 agonist , once-weekly dosing greatly improves compliance

Strong weight loss effect , clinical studies have shown excellent weight loss results

Cardiovascular protection , large-scale studies confirm cardiovascular and cerebrovascular benefits

Quality Assurance :

cGMP Manufacturing : Complies with Good Manufacturing Practices for Pharmaceuticals

Three-level quality control : full-process monitoring of raw materials, semi-finished products and finished products

Biopotency Assay : Ensure consistent activity across each batch of product

Professional Packaging :

Prefilled pens : convenient self-administration for patients

Cold chain transportation : 2-8°C temperature control throughout the entire process

Light protection : original packaging to protect from light and moisture

Summarize

Semaglutide is a breakthrough drug for the management of type 2 diabetes and obesity , particularly suitable for long-term glycemic control, significant weight loss, and cardiovascular risk reduction . The recommended dose is 0.5-2.4 mg/week .

Need a personalized plan?

We provide professional medical guidance to help you use the product safely and effectively!

Need anything, please contact us